Snooks H, Benger J, Bell F, Black S, Dixon S, Emery H
Health Technol Assess. 2024; 28(74):1-69.
PMID: 39487686
PMC: 11586806.
DOI: 10.3310/YNRC8249.
Todaro D, Volkow N, Langleben D, Shi Z, Wiers C
Neurosci Insights. 2024; 19:26331055241247156.
PMID: 39296815
PMC: 11409300.
DOI: 10.1177/26331055241247156.
Nikolova Y, Ruocco A, Felsky D, Lange S, Prevot T, Vieira E
medRxiv. 2024; .
PMID: 39252904
PMC: 11383479.
DOI: 10.1101/2024.08.30.24312806.
Gallant K, Nijjar P, DeBeck K, Cui M, Kerr T
J Addict Med. 2024; 19(1):105-108.
PMID: 39207346
PMC: 11790360.
DOI: 10.1097/ADM.0000000000001361.
Snooks H, Jones J, Bell F, Benger J, Black S, Dixon S
BMC Emerg Med. 2024; 24(1):155.
PMID: 39198758
PMC: 11360782.
DOI: 10.1186/s12873-024-01061-3.
Receipt of Opioid Agonist Treatment in provincial correctional facilities in British Columbia is associated with a reduced hazard of nonfatal overdose in the month following release.
McLeod K, Buxton J, Karim M, Martin R, Nosyk B, Kurz M
PLoS One. 2024; 19(7):e0306075.
PMID: 38985687
PMC: 11236203.
DOI: 10.1371/journal.pone.0306075.
Association between opioid use disorder and palliative care: a cohort study using linked health administrative data in Ontario, Canada.
Lau J, Scott M, Everett K, Gomes T, Tanuseputro P, Jennings S
CMAJ. 2024; 196(16):E547-E557.
PMID: 38684285
PMC: 11057880.
DOI: 10.1503/cmaj.231419.
Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration.
Cherian T, Lim S, Katyal M, Goldfeld K, McDonald R, Wiewel E
Drug Alcohol Depend. 2024; 259:111274.
PMID: 38643529
PMC: 11111329.
DOI: 10.1016/j.drugalcdep.2024.111274.
Incidence of rhabdomyolysis occurrence in psychoactive substances intoxication: a systematic review and meta-analysis.
Amanollahi A, Babeveynezhad T, Sedighi M, Shadnia S, Akbari S, Taheri M
Sci Rep. 2023; 13(1):17693.
PMID: 37848606
PMC: 10582156.
DOI: 10.1038/s41598-023-45031-4.
Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversals.
Holmen E, Warnqvist A, Kaberg M
Subst Abuse Treat Prev Policy. 2023; 18(1):24.
PMID: 37087485
PMC: 10121425.
DOI: 10.1186/s13011-023-00533-2.
Baseline characteristics of people experiencing homelessness with a recent drug overdose in the PHOENIx pilot randomised controlled trial.
Lowrie R, McPherson A, Mair F, Stock K, Jones C, Maguire D
Harm Reduct J. 2023; 20(1):46.
PMID: 37016418
PMC: 10071267.
DOI: 10.1186/s12954-023-00771-4.
Fatal and nonfatal opioid overdose risk following release from prison: A retrospective cohort study using linked administrative data.
Hartung D, McCracken C, Nguyen T, Kempany K, Waddell E
J Subst Use Addict Treat. 2023; 147:208971.
PMID: 36821990
PMC: 10795482.
DOI: 10.1016/j.josat.2023.208971.
Non-fatal opioid overdose after release from prison among men who injected drugs prior to their imprisonment: a prospective data linkage study.
Curtis M, Dietze P, Winter R, Rathnayake K, Smith K, Stoove M
Med J Aust. 2022; 218(2):94-95.
PMID: 36344250
PMC: 10952488.
DOI: 10.5694/mja2.51774.
Prevalence and associates of non-fatal overdose among people who inject drugs in Saveh, Iran.
Armoon B, Griffiths M, Bayani A, Mohammadi R, Ahounbar E
Addict Sci Clin Pract. 2022; 17(1):42.
PMID: 35927753
PMC: 9351099.
DOI: 10.1186/s13722-022-00325-2.
Fentanyl Test Strip Use and Overdose History among Individuals on Medication for Opioid Use Disorder.
Mistler C, Rosen A, Eger W, Copenhaver M, Shrestha R
Austin J Public Health Epidemiol. 2022; 8(5).
PMID: 35782633
PMC: 9249264.
Healthcare seeking among Swedish patients in opioid substitution treatment - a mixed methods study on barriers and facilitators.
Troberg K, Lundqvist K, Hansson H, Hakansson A, Dahlman D
Subst Abuse Treat Prev Policy. 2022; 17(1):8.
PMID: 35123518
PMC: 8817477.
DOI: 10.1186/s13011-022-00434-w.
Review of Neurologic Comorbidities in Hospitalized Patients With Opioid Abuse.
Nelson K, Dolbec K, Watson W, Yuan H, Ibraheem M
Neurol Clin Pract. 2022; 11(6):527-533.
PMID: 34992960
PMC: 8723930.
DOI: 10.1212/CPJ.0000000000001080.
Identifying pathways to recent non-fatal overdose among people who use opioids non-medically: How do psychological pain and unmet mental health need contribute to overdose risk?.
Tomko C, Schneider K, Rouhani S, Urquhart G, Park J, Morris M
Addict Behav. 2021; 127:107215.
PMID: 34953432
PMC: 9169246.
DOI: 10.1016/j.addbeh.2021.107215.
Growing racial/ethnic disparities in overdose mortality before and during the COVID-19 pandemic in California.
Friedman J, Hansen H, Bluthenthal R, Harawa N, Jordan A, Beletsky L
Prev Med. 2021; 153:106845.
PMID: 34653501
PMC: 8521065.
DOI: 10.1016/j.ypmed.2021.106845.
Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.
Davis C, Carr D, Glenn M, Samuels E
Ann Emerg Med. 2021; 78(1):102-108.
PMID: 33781607
PMC: 8238848.
DOI: 10.1016/j.annemergmed.2021.01.017.